{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:06:18Z","timestamp":1791183978349,"version":"4.1.0"},"reference-count":102,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":644,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/all.12324","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T05:48:03Z","timestamp":1385444883000},"page":"1509-1519","source":"Crossref","is-referenced-by-count":29,"title":["Atopic dermatitis and skin allergies - update and outlook"],"prefix":"10.1111","volume":"68","author":[{"given":"A.","family":"Wollenberg","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergy; Ludwig Maximilian University; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Feichtner","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy; Ludwig Maximilian University; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"10.1111\/all.12324-BIB0001|all12324-cit-0001","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1398-9995.2011.02571.x","article-title":"Atopic dermatitis - from new pathophysiologic insights to individualized therapy","volume":"66","author":"Novak","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0002|all12324-cit-0002","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/all.12067","article-title":"Update in clinical allergy and immunology","volume":"67","author":"Gunten","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0003|all12324-cit-0003","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/all.12324-BIB0004|all12324-cit-0004","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/all.12184","article-title":"Immunology of atopic eczema: overcoming the Th1\/Th2 paradigm","volume":"68","author":"Eyerich","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0005|all12324-cit-0005","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.12049","article-title":"Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0006|all12324-cit-0006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1398-9995.2010.02464.x","article-title":"Determinants of eczema: population-based cross-sectional study in Germany","volume":"66","author":"Apfelbacher","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0007|all12324-cit-0007","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1398-9995.2010.02512.x","article-title":"Atopy and current intestinal parasite infection: a systematic review and meta-analysis","volume":"66","author":"Feary","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0008|all12324-cit-0008","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/all.12216","article-title":"Vitamin A supplementation and BCG vaccination at birth may affect atopy in childhood: long-term follow-up of a randomized controlled trial","volume":"68","author":"Kiraly","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0009|all12324-cit-0009","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1398-9995.2012.02786.x","article-title":"Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort","volume":"67","author":"Ballardini","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0010|all12324-cit-0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1398-9995.2010.02507.x","article-title":"Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial","volume":"66","author":"Boyle","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0011|all12324-cit-0011","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.12112","article-title":"Characterization of different courses of atopic dermatitis in adolescent and adult patients","volume":"68","author":"Garmhausen","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0012|all12324-cit-0012","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2007.08112.x","article-title":"Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score","volume":"157","author":"Oranje","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/all.12324-BIB0013|all12324-cit-0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","article-title":"EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference","volume":"67","author":"Schram","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0014|all12324-cit-0014","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1398-9995.2011.02577.x","article-title":"Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe","volume":"66","author":"Stalder","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0015|all12324-cit-0015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2012.02874.x","article-title":"Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting","volume":"67","author":"Schmitt","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0016|all12324-cit-0016","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2012.02845.x","article-title":"Atopic dermatitis: a candidate for disease-modifying strategy","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0017|all12324-cit-0017","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12324-BIB0018|all12324-cit-0018","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.12051","article-title":"Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model","volume":"68","author":"Gschwandtner","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0019|all12324-cit-0019","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1111\/all.12324-BIB0020|all12324-cit-0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaci.2006.05.004","article-title":"Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations","volume":"118","author":"Weidinger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0021|all12324-cit-0021","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1398-9995.2012.02804.x","article-title":"Atopic diseases by filaggrin mutations and birth year","volume":"67","author":"Thyssen","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0022|all12324-cit-0022","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1398-9995.2010.02493.x","article-title":"Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0023|all12324-cit-0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0024|all12324-cit-0024","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1398-9995.2010.02540.x","article-title":"Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity","volume":"66","author":"Kezic","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0025|all12324-cit-0025","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"De Benedetto","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0026|all12324-cit-0026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12016-010-8227-x","article-title":"Innate immunity in atopic dermatitis","volume":"41","author":"Wollenberg","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/all.12324-BIB0027|all12324-cit-0027","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1398-9995.2000.00115.x","article-title":"Atopic dermatitis: from the genes to skin lesions","volume":"55","author":"Wollenberg","year":"2000","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0028|all12324-cit-0028","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/all.12239","article-title":"Many ways lead to Rome: a glance at the multiple immunological pathways underlying atopic dermatitis","volume":"68","author":"Bieber","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0029|all12324-cit-0029","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.175.5.1285","article-title":"Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI)","volume":"175","author":"Bieber","year":"1992","journal-title":"J Exp Med"},{"key":"10.1111\/all.12324-BIB0030|all12324-cit-0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4049\/jimmunol.157.2.607","article-title":"Peripheral blood dendritic cells express Fc\u03b5RI as a complex composed of Fc\u03b5RI\u03b1 and Fc\u03b5RI\u03b3-Chains and can use this Receptor for IgE-mediated Allergen presentation","volume":"157","author":"Maurer","year":"1996","journal-title":"J Immunol"},{"key":"10.1111\/all.12324-BIB0031|all12324-cit-0031","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1034\/j.1398-9995.2001.00144.x","article-title":"Epidemiology, clinical features, and immunology of the \u201cintrinsic\u201d (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis)","volume":"56","author":"Schmid-Grendelmeier","year":"2001","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0032|all12324-cit-0032","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1398-9995.2011.02760.x","article-title":"Demethylation of the FCER1G promoter leads to FcepsilonRI overexpression on monocytes of patients with atopic dermatitis","volume":"67","author":"Liang","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0033|all12324-cit-0033","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/0001555554193202","article-title":"Immunoglobulins in atopic dermatitis, with special reference to IgE","volume":"54","author":"Ohman","year":"1974","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/all.12324-BIB0034|all12324-cit-0034","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1046\/j.1365-2133.2000.03887.x","article-title":"Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis","volume":"143","author":"Oppel","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/all.12324-BIB0035|all12324-cit-0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2006.11.006","article-title":"Severe refractory atopic dermatitis in adults is highly atopic","volume":"119","author":"Salt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0036|all12324-cit-0036","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/all.12070","article-title":"The switch from non-IgE-associated to IgE-associated atopic dermatitis occurs early in life","volume":"68","author":"Dondi","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0037|all12324-cit-0037","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1398-9995.2011.02755.x","article-title":"The role of vitamin D in the immunopathogenesis of allergic skin diseases","volume":"67","author":"Benson","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0038|all12324-cit-0038","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1398-9995.2012.02824.x","article-title":"Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M","volume":"67","author":"Kanda","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0039|all12324-cit-0039","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1398-9995.2010.02513.x","article-title":"Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response","volume":"66","author":"Hartmann","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0040|all12324-cit-0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0041|all12324-cit-0041","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1398-9995.2011.02545.x","article-title":"Functional effects of interleukin 31 in human primary keratinocytes","volume":"66","author":"Kasraie","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0042|all12324-cit-0042","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1034\/j.1398-9995.2000.00432.x","article-title":"Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB)","volume":"55","author":"Breuer","year":"2000","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0043|all12324-cit-0043","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1398-9995.2008.01721.x","article-title":"Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism","volume":"63","author":"Niebuhr","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0044|all12324-cit-0044","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.1111\/all.12324-BIB0045|all12324-cit-0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1398-9995.2010.02483.x","article-title":"Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation","volume":"66","author":"Hong","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0046|all12324-cit-0046","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","article-title":"Viral infections in atopic dermatitis: pathogenic aspects and clinical management","volume":"112","author":"Wollenberg","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0047|all12324-cit-0047","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1128\/JVI.76.14.7203-7208.2002","article-title":"Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry","volume":"76","author":"Yoon","year":"2002","journal-title":"J Virol"},{"key":"10.1111\/all.12324-BIB0048|all12324-cit-0048","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","article-title":"Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases","volume":"119","author":"Wollenberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12324-BIB0049|all12324-cit-0049","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2005.12.1345","article-title":"Cathelicidin deficiency predisposes to eczema herpeticum","volume":"117","author":"Howell","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0050|all12324-cit-0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaci.2011.02.010","article-title":"Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response","volume":"127","author":"Leung","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0051|all12324-cit-0051","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/S0190-9622(03)00896-X","article-title":"Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases","volume":"49","author":"Wollenberg","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12324-BIB0052|all12324-cit-0052","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1398-9995.2010.02538.x","article-title":"Atopic dermo-respiratory syndrome is a correlate of eczema herpeticum","volume":"66","author":"Hinz","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0053|all12324-cit-0053","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","article-title":"ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis","volume":"24","author":"Darsow","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/all.12324-BIB0054|all12324-cit-0054","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/all.12201","article-title":"Where to prick the apple for skin testing?","volume":"68","author":"Vlieg-Boerstra","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0055|all12324-cit-0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11882-013-0368-6","article-title":"Patch testing for noncontact dermatitis: the atopy patch test for food and inhalants","volume":"13","author":"Wollenberg","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/all.12324-BIB0056|all12324-cit-0056","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11882-004-0072-7","article-title":"Lessons from atopy patch testing in atopic dermatitis","volume":"4","author":"Kerschenlohr","year":"2004","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/all.12324-BIB0057|all12324-cit-0057","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2222.1999.00510.x","article-title":"Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis","volume":"29","author":"Wistokat-Wulfing","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.12324-BIB0058|all12324-cit-0058","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1398-9995.2004.00556.x","article-title":"The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study","volume":"59","author":"Darsow","year":"2004","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0059|all12324-cit-0059","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/all.12071","article-title":"Atopy patch tests are useful to predict oral tolerance in children with gastrointestinal symptoms related to non-IgE-mediated cow's milk allergy","volume":"68","author":"Nocerino","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0060|all12324-cit-0060","article-title":"Allergic and immunodeficiency findings in atopic dermatitis and hyper-IgE syndrome patients - recommendations for a clinical workup","author":"Wollenberg","year":"2014","journal-title":"Chem Immunol Allergy"},{"key":"10.1111\/all.12324-BIB0061|all12324-cit-0061","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","article-title":"Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis","volume":"126","author":"Schimke","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0062|all12324-cit-0062","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.iac.2010.06.005","article-title":"Evolution of conventional therapy in atopic dermatitis","volume":"30","author":"Wollenberg","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1111\/all.12324-BIB0063|all12324-cit-0063","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-6-6","article-title":"Difficult to control atopic dermatitis","volume":"6","author":"Darsow","year":"2013","journal-title":"World Allergy Organ J"},{"key":"10.1111\/all.12324-BIB0064|all12324-cit-0064","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1398-9995.2006.00974.x","article-title":"Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study","volume":"61","author":"Werfel","year":"2006","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0065|all12324-cit-0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) part I","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/all.12324-BIB0066|all12324-cit-0066","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) Part II","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/all.12324-BIB0067|all12324-cit-0067","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1398-9995.2011.02747.x","article-title":"Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis","volume":"67","author":"Jensen","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0068|all12324-cit-0068","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaci.2004.03.021","article-title":"Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis","volume":"114","author":"Schuller","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12324-BIB0069|all12324-cit-0069","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1398-9995.2005.00798.x","article-title":"Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment","volume":"60","author":"Simon","year":"2005","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0070|all12324-cit-0070","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1398-9995.2008.01683.x","article-title":"Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment","volume":"63","author":"Wollenberg","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0071|all12324-cit-0071","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1398-9995.2008.01803.x","article-title":"Proactive therapy of atopic dermatitis-an emerging concept","volume":"64","author":"Wollenberg","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0072|all12324-cit-0072","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5021\/ad.2012.24.3.253","article-title":"Long term treatment concepts and proactive therapy for atopic eczema","volume":"24","author":"Wollenberg","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1111\/all.12324-BIB0073|all12324-cit-0073","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1398-9995.2012.02854.x","article-title":"The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC\/Nga mice","volume":"67","author":"Ohsawa","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0074|all12324-cit-0074","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1398-9995.2012.02789.x","article-title":"Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial","volume":"67","author":"Pfab","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0075|all12324-cit-0075","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1398-9995.2012.02844.x","article-title":"Topical application of PPARalpha (but not beta\/delta or gamma) suppresses atopic dermatitis in NC\/Nga mice","volume":"67","author":"Chiba","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0076|all12324-cit-0076","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1398-9995.2012.02834.x","article-title":"Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK)","volume":"67","author":"Schnuch","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0077|all12324-cit-0077","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1398-9995.2012.02863.x","article-title":"The association between contact sensitization and atopic disease by linkage of a clinical database and a nationwide patient registry","volume":"67","author":"Thyssen","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0078|all12324-cit-0078","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/all.12041","article-title":"Systemic contact dermatitis to corticosteroids","volume":"67","author":"Baeck","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0079|all12324-cit-0079","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/all.12183","article-title":"Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors","volume":"68","author":"Gaffal","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0080|all12324-cit-0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0081|all12324-cit-0081","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.12068","article-title":"Psychosocial factors and chronic spontaneous urticaria: a systematic review","volume":"68","author":"Ben-Shoshan","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0082|all12324-cit-0082","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1398-9995.2011.02580.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper","volume":"66","author":"Baiardini","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0083|all12324-cit-0083","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/all.12171","article-title":"Up-dosing with bilastine results in improved effectiveness in cold contact urticaria","volume":"68","author":"Krause","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0084|all12324-cit-0084","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1398-9995.2010.02472.x","article-title":"Omalizumab-an effective and safe treatment of therapy-resistant chronic spontaneous urticaria","volume":"66","author":"Groffik","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0085|all12324-cit-0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/all.12078","article-title":"Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine","volume":"68","author":"Hiragun","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0086|all12324-cit-0086","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1398-9995.2010.02506.x","article-title":"Increase of coagulation potential in chronic spontaneous urticaria","volume":"66","author":"Takeda","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0087|all12324-cit-0087","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/all.12030","article-title":"How not to miss autoinflammatory diseases masquerading as urticaria","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0088|all12324-cit-0088","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/all.12153","article-title":"Practical algorithm for diagnosing patients with recurrent wheals or angioedema","volume":"68","author":"Maurer","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0089|all12324-cit-0089","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/all.12056","article-title":"EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria","volume":"68","author":"Konstantinou","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0090|all12324-cit-0090","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1398-9995.2011.02704.x","article-title":"Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation","volume":"66","author":"Bossi","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0091|all12324-cit-0091","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1398-9995.2011.02684.x","article-title":"Response to a selective COX-2 inhibitor in patients with urticaria\/angioedema induced by nonsteroidal anti-inflammatory drugs","volume":"66","author":"Dona","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0092|all12324-cit-0092","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/all.12138","article-title":"Skin recruitment of monomyeloid precursors involves human herpesvirus-6 reactivation in drug allergy","volume":"68","author":"Hashizume","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0093|all12324-cit-0093","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0094|all12324-cit-0094","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/all.12105","article-title":"Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment","volume":"68","author":"Madrigal-Burgaleta","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0095|all12324-cit-0095","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0096|all12324-cit-0096","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1398-9995.2010.02495.x","article-title":"Generalised delayed desquamative exanthema after intradermal testing with betalactam antibiotics","volume":"66","author":"Sala Cunill","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0097|all12324-cit-0097","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1398-9995.2011.02661.x","article-title":"The in vitro diagnosis of drug allergy: status and perspectives","volume":"66","author":"Ebo","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0098|all12324-cit-0098","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2010.02460.x","article-title":"In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones","volume":"66","author":"Aranda","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0099|all12324-cit-0099","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1398-9995.2011.02720.x","article-title":"Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells","volume":"67","author":"Daubner","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0100|all12324-cit-0100","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1398-9995.2012.02867.x","article-title":"Biological and genetic determinants of atopy are predictors of immediate-type allergy to betalactams Spain","volume":"67","author":"Cornejo-Garcia","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0101|all12324-cit-0101","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/all.12196","article-title":"Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphisms","volume":"68","author":"Bursztejn","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12324-BIB0102|all12324-cit-0102","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1398-9995.2011.02554.x","article-title":"Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients","volume":"66","author":"Waton","year":"2011","journal-title":"Allergy"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12324","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T11:12:01Z","timestamp":1716203521000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.12324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":102,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12324","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}